Thromboembolic risk in atrial flutter

European Heart Journal

Volumn 22, Issue 12, 2001, Pages 1042-1051

  Corrado, Giovanni ^a   Sgalambro, A ^b   Mantero, A ^c   Gentile, F ^d   Gasparini, M ^e   Bufalino, R ^e   Morabito, A ^f   Trocino, G ^g   Schiavina, R ^g   Mandorla, S ^h   Mangia, R ⁱ   Tovena, D ^j   Savino, K ^k   Jacopi, F ^l   Pellegrino, E M ^m   Agostini, F ⁿ   Centonze, G ^o   Bovenzi, F ^p   Caprino, E ^q   Tadeo, G ^a   Santarone, M ^a   more..

^a Ospedale Generale Valduce   (Italy)

^b Ospedale Civile Di Vicenza   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

^d Ospedale Bassini   (Italy)

^e HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g SAN GERARDO HOSPITAL   (Italy)

^h Ospedale Silvestrini   (Italy)

ⁱ Ospedale Cardinale Panico   (Italy)

^j MAGGIORE HOSPITAL   (Italy)

^k UNIVERSITY OF PERUGIA   (Italy)

^l Dipartimento di Cardiologia   (Italy)

^m Sacro Cuore di Gesù Hospital   (Italy)

ⁿ CARLO POMA HOSPITAL   (Italy)

^o Ospedale Civile di Matera   (Italy)

^p POLICLINICO   (Italy)

^q Ospedale Civile   (Italy)

more..

Author keywords

Atrial flutter; Echocardiography; Thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL TRIAL; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FLUTTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; ANALYSIS OF VARIANCE; ANTICOAGULANTS; AORTIC DISEASES; ARTERIOSCLEROSIS; ATRIAL FLUTTER; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIA; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; THROMBOEMBOLISM;

EID: 0034898250     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2000.2427     Document Type: Article

References (52)

1. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study
2. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: The Copenhagen AFA-SAK study
3. Preliminary report of the Stroke Prevention in Atrial Fibrillation Study
4. The effect of low-dose warfarin on risk of stroke in patients with nonrheumatic atrial fibrillation
5. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials
6. Prognostic implication of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation
7. Atrial fibrillation with left atrial spontaneous contrast detected by transesophageal echocardiography is a potent risk factor for stroke
8. Thromboembolic risk of left atrial thrombus detected by transesophageal echocardiogram
9. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation
10. Antithrombotic therapy in atrial fibrillation
11. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter
12. Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: A transesophageal echocardiographic study
13. Left atrial appendage function in patients with atrial flutter
14. Prevention of embolic events after cardioversion of atrial fibrillation: Current and evolving strategies
15. Thromboembolic risk of atrial flutter
16. Prevalence of intraatrial thrombus in patients with atrial flutter
17. Prevalence of thrombus, spontaneous echocontrast, and atrial stunning in patients undergoing cardioversion of atrial flutter. A prospective study using transesophageal echocardiography
18. TEE-guided early cardioversion of atrial flutter: Results from the Acute Trial registry
19. Incidence of atrial thrombi in patients with first presentation of atrial flutter undergoing electrical cardioversion. A prospective study
20. Risk of thromboembolic events in patients with atrial flutter
21. Acute changes in spontaneous echocontrast and atrial function after cardioversion of persistent atrial flutter
22. Le Flutter et ses limites
23. Entrainment and interruption of atrial flutter with atrial pacing: Studies in man following open heart surgery
24. Normal adult cross sectional echocardiographic values: Linear dimensions and chamber areas
25. Assessment of left atrial dimensions by cross sectional echocardiography in patients with mitral valve disease
26. Reccomendations regarding quantitation in M-Mode echocardiography: Results of a survey of echocardiogtraphic masurements
27. Color Doppler assessment of mitral regurgitation with orthogonal planes
28. Critical appraisal of transesophageal echocardiography: Limitations, pitfalls, and complications
29. Usefulness of multiplane transesophageal echocardiography in differentiating left atrial appendage thrombus from pectinate muscles
30. Prevalence and clinical implications of atrial spontaneous contrast in patients under-going transesophageal echocardiography
31. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo
32. Cardiac tumors and masses
33. Transesophageal echocardiography in thoracic aortic atherosclerosis
34. High prevalence of left atrial thrombi in patients with typical atrial flutter and left ventricular systolic dysfunction
35. Cardioversion guided by transesophageal echocardiography: The ACUTE pilot study. A randomized, controlled trial
36. Accuracy of biplane transesophageal echocardiography in detecting left atrial thrombus
37. Assessment of left atrial appendage function by transesophageal echocardiography. Implications for the development of thrombus
38. Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation
39. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: Final results of a prospective 4.5-year study
40. Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation. A transesophageal echocardiographic study
41. Thromboembolic risk of atrial flutter: Is the risk underestimated?
42. Thromboembolism in chronic atrial flutter: Is the risk underestimated?
43. Thromboembolism following cardioversion of "common" atrial flutter. Risk factors and limitations of transesophageal echocardiography
44. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study
45. Impact of electrical cardioversion of atrial fibrillation on left atrial appendage function and spontaneous echo contrast: Characterization by simultaneous transesophageal echocardiography
46. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: Evidence for "atrial stunning" as a mechanism of thromboembolic complications
47. Left atrial appendage "stunning" after spontaneous conversion of atrial fibrillation demonstrated by transesophageal Doppler echocardiography
48. Atrial stunning lasts more than one week after cardioversion of atrial flutter
49. Left atrial appendage "stunning" after electrical cardioversion: An attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events
50. Left atrial "stunning" following radiofrequency catheter ablation of chronic atrial flutter
51. Impairment of left atrial appendage function after spontaneous conversion of atrial flutter
52. The alternation between atrial flutter and atrial fibrillation